snRNP core protein D1
|
|
- $290.7 - $729
- Product name: snRNP core protein D1
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:ANTI-SNRPD1 (CENTER) antibody produced in rabbit;ANTI-SNRPD1(C-TERMINAL) antibody produced in rabbit;Small nuclear ribonucleoprotein Sm D1;snRNP core protein D1;SNRPD1;Sm-D autoantigen
4 prices
Selected condition：
Brand
- Biorbyt Ltd
- Sigma-Aldrich
- Usbiological
Package
- 10μg
- 96Tests
- 400μL
- ManufacturerBiorbyt Ltd
- Product numberorb597910
- Product descriptionSNRPD1
- Packaging10μg
- Price$290.7
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB1307174
- Product descriptionANTI-SNRPD1(C-TERMINAL) antibody produced in rabbit purified immunoglobulin, buffered aqueous solution
- Packaging400μL
- Price$461
- Updated2023-01-07
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB1307175
- Product descriptionANTI-SNRPD1 (CENTER) antibody produced in rabbit purified immunoglobulin, buffered aqueous solution
- Packaging400μl
- Price$496
- Updated2025-07-31
- Buy
- ManufacturerUsbiological
- Product number384457
- Product descriptionSNRPD1
- Packaging96Tests
- Price$729
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biorbyt Ltd | orb597910 | SNRPD1 | 10μg | $290.7 | 2021-12-16 | Buy |
| Sigma-Aldrich | SAB1307174 | ANTI-SNRPD1(C-TERMINAL) antibody produced in rabbit purified immunoglobulin, buffered aqueous solution | 400μL | $461 | 2023-01-07 | Buy |
| Sigma-Aldrich | SAB1307175 | ANTI-SNRPD1 (CENTER) antibody produced in rabbit purified immunoglobulin, buffered aqueous solution | 400μl | $496 | 2025-07-31 | Buy |
| Usbiological | 384457 | SNRPD1 | 96Tests | $729 | 2021-12-16 | Buy |
Properties
storage temp. :-20°C
form :buffered aqueous solution
biological source :rabbit
form :buffered aqueous solution
biological source :rabbit
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|